Industry-chain Research Brief

Zhongrong Technology Corporation Ltd: Biomedicine and medical devices Little Giant Industry Chain Brief

Hebei · Biomedicine and medical devices · 2026-06-14

English company profile Full Chinese report All report summaries

English Summary

Zhongrong Technology Corporation Ltd is a China Little Giant company report summary for overseas readers. The company is associated with Hebei. The report is indexed under Biomedicine and medical devices. The Chinese report was published on 2026-06-14. The summary covers company profile, product direction, industry-chain role, technology, patent/R&D signals, scale indicators and policy-material checkpoints.

Report Snapshot

CompanyZhongrong Technology Corporation Ltd
RegionHebei
IndustryBiomedicine and medical devices
Published2026-06-14
Chinese reportOpen
CompanyZhongrong Technology Corporation Ltd
Region / IndustryHebei · Biomedicine and medical devices
Recognition2021 3rd batch
Patent signal92 patent-related records

Company and Recognition Snapshot

Zhongrong Technology Corporation Ltd is indexed as a national-level Little Giant enterprise in Hebei. The English profile places the company under Biomedicine and medical devices and records 2021 3rd batch as the available recognition context.

Recognition batch2021 3rd batch
RegionHebei
IndustryBiomedicine and medical devices
Registered capitalRMB 143.84 million
Employee signal104 employees
Listed statusStatus recorded on the Chinese profile
Patent signal92 patent-related records
R&D signalR&D investment detail not published in the English dataset

Business and Industry-chain Position

Chinese public records indicate testing, inspection and technical-service activity, R&D, design and engineering activity. The recorded industry-chain position is Recorded industry-chain role / Recorded position. This places the company in a policy-relevant segment for peer comparison by region, industry and batch.

Technology, Patent and R&D Signals

The public profile records 92 patent-related records. The R&D signal is: R&D investment detail not published in the English dataset. Patent and R&D information should be read with product direction, customer evidence and chain position rather than as isolated threshold items.

Policy-material Review Points

  • Verify whether the company's main business, niche market and product evidence all point to Biomedicine and medical devices.
  • Check that patent, R&D, employee and financial fields support the same core product direction.
  • Compare the company with peers in the same province, industry and recognition batch before using the profile for supplier screening or policy research.
  • Use the linked Chinese source report for original-language evidence and source links.

Original Report and Profile

For the underlying database record, open the English company profile. For full-length analysis, original-language wording and public evidence links, open the Chinese source report.

Related Search Paths